Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T O'Neill

Showing results (11-20 of 381) with videos related to

Pageof 39
Sort By:
BMJ (Clinical Research Ed.)|May 24, 2012
Patients have the right to be informed about an errorAideen T O'Neill
Drug Information Journal|December 11, 1986
Statistical analyses of adverse event data from clinical trials. Special emphasis on serious eventsR T O'Neill
BMJ (Clinical Research Ed.)|October 1, 2010
Make systems fit for purposeAideen T O'Neill
Statistics in Medicine|September 28, 1998
Biostatistical considerations in pharmacovigilance and pharmacoepidemiology: linking quantitative risk assessment in pre-market licensure application safety data, post-market alert reports and formal epidemiological studiesR T O'Neill
American Journal of Obstetrics and Gynecology|September 15, 1970
Pregnancy following hormonal therapy for adenocarcinoma of the endometriumR T O'Neill
Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement|March 1, 1996
Voice of the victims--the key to consensus and support for alcoholism researchJ T O'Neill
Nursing Management|June 1, 1990
Professionalism must be rewardedM T O'Neill
Statistics in Medicine|September 27, 2002
Regulatory perspectives on data monitoringRobert T O'Neill
Contemporary Clinical Trials|November 13, 2020
Reacting to crises: The COVID-19 impact on biostatistics/epidemiologyRobert T O'Neill
Statistics in Medicine|December 1, 1988
On sample sizes to estimate the protective efficacy of a vaccineR T O'Neill
Pageof 39

Showing results (11-20 of 381) with videos related to

Sort By:
Pageof 39
BMJ (Clinical Research Ed.)|May 24, 2012
Patients have the right to be informed about an errorAideen T O'Neill
Drug Information Journal|December 11, 1986
Statistical analyses of adverse event data from clinical trials. Special emphasis on serious eventsR T O'Neill
BMJ (Clinical Research Ed.)|October 1, 2010
Make systems fit for purposeAideen T O'Neill
Statistics in Medicine|September 28, 1998
Biostatistical considerations in pharmacovigilance and pharmacoepidemiology: linking quantitative risk assessment in pre-market licensure application safety data, post-market alert reports and formal epidemiological studiesR T O'Neill
American Journal of Obstetrics and Gynecology|September 15, 1970
Pregnancy following hormonal therapy for adenocarcinoma of the endometriumR T O'Neill
Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement|March 1, 1996
Voice of the victims--the key to consensus and support for alcoholism researchJ T O'Neill
Nursing Management|June 1, 1990
Professionalism must be rewardedM T O'Neill
Statistics in Medicine|September 27, 2002
Regulatory perspectives on data monitoringRobert T O'Neill
Contemporary Clinical Trials|November 13, 2020
Reacting to crises: The COVID-19 impact on biostatistics/epidemiologyRobert T O'Neill
Statistics in Medicine|December 1, 1988
On sample sizes to estimate the protective efficacy of a vaccineR T O'Neill
Pageof 39